- Home
- AEON vs GROW Comparison
AEON vs GROW Comparison
Compare AEON & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- GROW
- Stock Information
- Founded
- AEON N/A
- GROW 1968
- Country
- AEON United States
- GROW United States
- Employees
- AEON N/A
- GROW N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- AEON Health Care
- GROW Finance
- Exchange
- AEON Nasdaq
- GROW Nasdaq
- Market Cap
- AEON 38.4M
- GROW 35.6M
- IPO Year
- AEON N/A
- GROW N/A
- Fundamental
- Price
- AEON $0.73
- GROW $2.58
- Analyst Decision
- AEON Strong Buy
- GROW
- Analyst Count
- AEON 1
- GROW 0
- Target Price
- AEON $5.00
- GROW N/A
- AVG Volume (30 Days)
- AEON 97.3K
- GROW 18.6K
- Earning Date
- AEON 11-11-2024
- GROW 09-10-2024
- Dividend Yield
- AEON N/A
- GROW 3.50%
- EPS Growth
- AEON N/A
- GROW N/A
- EPS
- AEON 0.99
- GROW 0.09
- Revenue
- AEON N/A
- GROW $10,984,000.00
- Revenue This Year
- AEON N/A
- GROW N/A
- Revenue Next Year
- AEON N/A
- GROW N/A
- P/E Ratio
- AEON $0.75
- GROW $28.61
- Revenue Growth
- AEON N/A
- GROW N/A
- 52 Week Low
- AEON $0.71
- GROW $2.47
- 52 Week High
- AEON $17.17
- GROW $3.11
- Technical
- Relative Strength Index (RSI)
- AEON 31.89
- GROW 49.94
- Support Level
- AEON $0.72
- GROW $2.53
- Resistance Level
- AEON $0.89
- GROW $2.58
- Average True Range (ATR)
- AEON 0.07
- GROW 0.05
- MACD
- AEON 0.01
- GROW 0.00
- Stochastic Oscillator
- AEON 12.01
- GROW 33.33
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company furnishes an investment program for each of the clients it manages and determines, subject to overall supervision by the applicable board of trustees of the clients, the clients investments pursuant to an advisory agreement. US Global manages the following business segments: Investment management services; Investment management services; and Corporate Investments. It derives all its revenue from Investment management services.